Dumont & Blake Investment Advisors LLC Bluebird Bio, Inc. Transaction History

Dumont & Blake Investment Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 07, 2019	SELL	$59.1 - $93.26 $265,950 - $419,670	-4,500 Closed	0 $0
Q3 2018 Oct 19, 2018	BUY	$88.86 - $117.49 $8,886 - $11,749	100 Added 2.27%	4,500 $657,000
Q2 2018 Jul 25, 2018	BUY	$99.64 - $127.59 $39,856 - $51,036	400 Added 10.0%	4,400 $691,000
Q1 2018 Apr 26, 2018	BUY	$105.8 - $150.94 $423,200 - $603,760	4,000 New	4,000 $683,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Dumont & Blake Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Dumont & Blake Investment Advisors LLC with notifications on news.